Company intelligence / Profile preview

MonoGen

Lincolnshire, Illinois, USA

Ownership: Private
Development stage: Other

Overview

MonoGen was a medical technology company specializing in liquid-based cytology for cancer screening and diagnostics. The company developed the MonoPrep system, an automated liquid-based Pap testing platform designed to improve the detection of cervical cancer and its precursors. By utilizing a proprietary filtration and cell-transfer process, the system provided high-quality cellular slides for clinical review, aiming to reduce false negatives compared to traditional methods. MonoGen was acquired by Cytyc Corporation in 2004 for approximately $21.7 million. Its technologies were subsequently integrated into the Hologic portfolio following the merger of Cytyc and Hologic.

Therapeutic areas: Oncology
Modalities: Device
Industry: Pathology

Beyond the preview

Go deeper on MonoGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MonoGen.

Explore the full profile